HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Faculty of Pharmaceutical Sciences >
Peer-reviewed Journal Articles, etc >

In vitro optimization of 2 '-OMe-4 '-thioribonucleoside-modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle

Files in This Item:
WoS_64354_Matsuda_Akira.pdf1.24 MBPDFView/Open
WoS_64354_Matsuda_Akira_Supplementary_Data.pdfSupplementary data203.27 kBPDFView/Open
Please use this identifier to cite or link to this item:

Title: In vitro optimization of 2 '-OMe-4 '-thioribonucleoside-modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle
Authors: Takahashi, Mayumi Browse this author
Yamada, Naoki Browse this author
Hatakeyama, Hiroto Browse this author →KAKEN DB
Murata, Manami Browse this author
Sato, Yusuke Browse this author
Minakawa, Noriaki Browse this author
Harashima, Hideyoshi Browse this author →KAKEN DB
Matsuda, Akira Browse this author →KAKEN DB
Issue Date: Dec-2013
Publisher: Oxford univ press
Journal Title: Nucleic acids research
Volume: 41
Issue: 22
Start Page: 10659
End Page: 10667
Publisher DOI: 10.1093/nar/gkt823
PMID: 24030710
Abstract: MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression post-transcriptionally. Previous studies, which characterized miRNA function, revealed their involvement in fundamental biological processes. Importantly, miRNA expression is deregulated in many human diseases. Specific inhibition of miRNAs using chemically modified anti-miRNA oligonucleotides (AMOs) can be a potential therapeutic strategy for diseases in which a specific miRNA is overexpressed. 2'-O-Methyl (2'-OMe)-4'-thioRNA is a hybrid type of chemically modified oligonucleotide, exhibiting high binding affinity to complementary RNAs and high resistance to nuclease degradation. Here, we evaluate 2'-OMe-4'-thioribonucleosides for chemical modification on AMOs. Optimization of the modification pattern using a variety of chemically modified AMOs that are perfectly complementary to mature miR-21 revealed that the uniformly 2'-OMe-4'-thioribonucleoside modified AMO was most potent. Further investigation showed that phosphorothioate modification contributed to long-term miR-122 inhibition by the 2'-OMe-4'-thioribonucleoside-modified AMO. Moreover, systemically administrated AMOs to mouse using a liposomal delivery system, YSK05-MEND, showed delivery to the liver and efficient inhibition of miR-122 activity at a low dose in vivo.
Type: article
Appears in Collections:薬学研究院 (Faculty of Pharmaceutical Sciences) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 松田 彰

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 - Hokkaido University